A post hoc analysis of the long-term safety and efficacy of perampanel in Asian patients with epilepsy-Reference-Cited by-同舟云学术

A post hoc analysis of the long-term safety and efficacy of perampanel in Asian patients with epilepsy

Published:2019-03 Issue: Volume:60 Page:60-67
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Inoue Yushi¹,Kaneko Sunao²,Hsieh Peiyuan F.³,Meshram Chandrashekhar⁴,Lee Sang-Ahm⁵,Aziz Zariah Abdul⁶,Nabangchang Charcrin⁷,Dash Amitabh⁸^ORCID

Affiliation:

1. National Epilepsy Center; NHO Shizuoka Institute of Epilepsy and Neurological Disorders; Shizuoka Japan

2. North Tohoku Epilepsy Center; Minato Hospital; Hachinohe Japan

3. Taichung Veterans General Hospital; Taichung City Taiwan

4. Brain and Mind Institute; Nagpur India

5. Asan Medical Center; Seoul South Korea

6. Hospital Sultanah Nur Zahirah; Terengganu Malaysia

7. Comprehensive Epilepsy Center; Phramongkutklao College of Medicine; Bangkok Thailand

8. Eisai Singapore Pte. Ltd.; Singapore

Funder

Eisai Co., Ltd.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.14645/fullpdf

Reference20 articles.

1. Glutamate receptor ion channels: structure, regulation, and function;Traynelis;Pharmacol Rev,2010

2. Revisiting AMPA receptors as an antiepileptic drug target;Rogawski;Epilepsy Curr,2011

3. Food and Drug Administration Fycompa ® Prescribing Information 2018 https://www.fycompa.com/-/media/Files/Fycompa/Fycompa_Prescribing_Information.pdf

4. European Medicines Agency Fycompa ® Annex I: Summary of Product Characteristics 2017 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf

5. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304;French;Neurology,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study;Journal of the Neurological Sciences;2024-08

2. Time to prerandomization seizure count design sufficiently assessed the safety and tolerability of perampanel for the treatment of primary generalized tonic–clonic seizures;Epilepsia;2024-06-12

3. Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study;Journal of Neurology;2024-05-08

4. Long‐term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial;Clinical and Translational Science;2024-05

5. Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study;Epilepsia Open;2023-09-25